Cargando…

P428 Evaluation of Galactomannan enzyme assay in non-hematological non-neutropenic ICU admitted patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019

POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVE: The objective of this study was to evaluate galactomannan enzyme assay in non-hematological ICU patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019. METHODS: Galactomannan detection in serum samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashyap, Sanchi, Capoor, Malini R., Lavanya, P., Gupta, Poonam, Verma, P.K., Talwar, Vandana, Sachdeva, Harish Chand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515921/ http://dx.doi.org/10.1093/mmy/myac072.P428

Ejemplares similares

Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies
por: Gupta, Ankit, et al.
Publicado: (2017)

Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction
por: Lopes da Silva, Rodrigo, et al.
Publicado: (2010)

Performance of Two Commercial Assays for the Detection of Serum Aspergillus Galactomannan in Non-Neutropenic Patients
por: Almeida-Paes, Rodrigo, et al.
Publicado: (2022)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

P036 Epidemiology and antifungal susceptibility profile of infections caused by Fusarium species
por: Capoor, Malini R, et al.
Publicado: (2022)

Concomitant Infections of Influenza A H1N1 and Disseminated Cryptococcosis in an HIV Seropositive Patient
por: Gupta, Ankit, et al.
Publicado: (2015)

361. Think Fungus! – Clinical profile, Risk factors and Diagnostic Utility of Galactomannan in diagnosis of Invasive Aspergillosis in Non-Neutropenic patients – A Prospective Study from India
por: Ravindra, Akshatha, et al.
Publicado: (2022)

P050 Candida auris and non- auris candidemia in adult patients in a tertiary care set-up, New Delhi, India
por: Jangra, Priyanka, et al.
Publicado: (2022)

Serum galactomannan levels in the diagnosis of invasive aspergillosis
por: Okuturlar, Yildiz, et al.
Publicado: (2015)

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
por: Trof, R. J., et al.
Publicado: (2007)

How to manage aspergillosis in non-neutropenic intensive care unit patients
por: Bassetti, Matteo, et al.
Publicado: (2014)

Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
por: Bassetti, Matteo, et al.
Publicado: (2017)

Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis
por: Dai, Zhang, et al.
Publicado: (2021)

Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp
por: Barberán, José, et al.
Publicado: (2017)

Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
por: Cao, Xun-Jie, et al.
Publicado: (2020)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022)

Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing()
por: Garnica, Marcia, et al.
Publicado: (2016)

747. Diagnostic Performance of Bronchoalveolar Lavage Fluid Galactomannan Assay in Patients with Negative Serum Galactomannan Assay Suspected with Invasive Pulmonary Aspergillosis
por: Lim, So Yun, et al.
Publicado: (2020)

Serum galactomannan in histoplasmosis in HIV
por: Baidya, Ankita, et al.
Publicado: (2022)

Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
por: Dufresne, Simon F., et al.
Publicado: (2012)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018)

Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
por: Zhuang, Qidong, et al.
Publicado: (2017)

Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study
por: Bao, Shujun, et al.
Publicado: (2022)

Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Zhu, Ning, et al.
Publicado: (2023)

Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
por: Han, Seung Beom, et al.
Publicado: (2015)

The Diagnosis of Invasive and Noninvasive Pulmonary Aspergillosis by Serum and Bronchoalveolar Lavage Fluid Galactomannan Assay
por: Zhang, Shuzhen, et al.
Publicado: (2015)

Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis
por: Khodavaisy, S, et al.
Publicado: (2015)

Long-Term Kinetics of Serum Galactomannan during Treatment of Complicated Invasive Pulmonary Aspergillosis
por: Tragiannidis, Athanasios, et al.
Publicado: (2023)

Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole
por: Bassetti, Matteo, et al.
Publicado: (2018)

A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma
por: Uchida, Yoshinori, et al.
Publicado: (2022)

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

Performance of the bronchoalveolar lavage fluid later-flow device test in the rapid diagnosis of non-neutropenic invasive pulmonary aspergillosis
por: Liu, Lu-Lu, et al.
Publicado: (2020)

NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients
por: Zhong, Jinjin, et al.
Publicado: (2022)

P144 The uncommon meets the common: Invasive Aspergillosis and tuberculosis co-infection in non-neutropenic patients— arare association
por: R, Akshatha, et al.
Publicado: (2022)

Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients
por: Hsu, Li-Yang, et al.
Publicado: (2010)

Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis
por: Zou, Mingxiang, et al.
Publicado: (2012)

Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics
por: Mercier, Toine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekgnrl4u82alcs5bocudmooqoi